(Q38119437)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828432%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

Thyroid nodules and differentiated thyroid cancer: update on the Brazilian consensus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828432%20AND%20SRC:MED&resulttype=core&format=json

differentiated thyroid carcinoma

4 March 2020

main subject

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828432%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Pedro Weslley Rosário

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828432%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Laura S Ward

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828432%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Gisah A Carvalho

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828432%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Hans Graf

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828432%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Rui M B Maciel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828432%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Léa Maria Z Maciel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828432%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Mário Vaisman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828432%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Sociedade Brasileira de Endocrinologia e Metabologia

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828432%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

1 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828432%20AND%20SRC:MED&resulttype=core&format=json

Arquivos Brasileiros de Endocrinologia e Metabologia

4 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828432%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828432%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828432%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

240-264

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828432%20AND%20SRC:MED&resulttype=core&format=json

The significance of nontoxic thyroid nodules. Final report of a 15-year study of the incidence of thyroid malignancy

4 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Thyroid incidentalomas: management approaches to nonpalpable nodules discovered incidentally on thyroid imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Clinical practice. The thyroid nodule

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

A cohort study of thyroid cancer and other thyroid diseases after the chornobyl accident: thyroid cancer in Ukraine detected during first screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Thyroid nodules: rational management

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Hashimoto's thyroiditis is not associated with increased risk of thyroid cancer in patients with thyroid nodules: a single-center prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Interest of routine measurement of serum calcitonin: study in a large series of thyroidectomized patients. The French Medullary Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in 10,864 patients with nodular thyroid disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: A multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Usefulness of ultrasonography in the management of nodular thyroid disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Preoperative staging of thyroid papillary carcinoma with ultrasonography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Thyroid nodules: evaluation with power Doppler and duplex Doppler ultrasound.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Prospective evaluation of thyroid imaging reporting and data system on 4550 nodules with and without elastography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

What is the contribution of elastography to thyroid nodules evaluation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Evaluation of substernal goiters using computed tomography and MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Disparate thyroid imaging. Combined studies with sodium pertechnetate Tc 99m and radioactive iodine

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Contribution of scintigraphy and ultrasonography to the prediction of malignancy in thyroid nodules with indeterminate cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

An observational trial for papillary thyroid microcarcinoma in Japanese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

The Bethesda System for Reporting Thyroid Cytopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

How to combine ultrasound and cytological information in decision making about thyroid nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Value of repeat ultrasound-guided fine-needle aspiration in thyroid nodule with a first benign cytologic result: impact of ultrasound to predict malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Differential expression of galectin-3, CK19, HBME1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Current state and future perspective of molecular diagnosis of fine-needle aspiration biopsy of thyroid nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

MicroRNA signature in thyroid fine needle aspiration cytology applied to "atypia of undetermined significance" cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Preoperative diagnosis of benign thyroid nodules with indeterminate cytology

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Effectiveness of thyroid hormone suppressive therapy in benign solitary thyroid nodules: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Thyroxine suppression therapy for benign, non-functioning solitary thyroid nodules: a quality-effects meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

The clinical significance of subclinical thyroid dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Changes associated with percutaneous ethanol injection in the treatment of thyroid nodules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Non-surgical approach to the benign nodular goiter: new opportunities by recombinant human TSH-stimulated 131I-therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Modified-release recombinant human TSH (MRrhTSH) augments the effect of (131)I therapy in benign multinodular goiter: results from a multicenter international, randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Recombinant human thyrotropin as adjuvant in the treatment of multinodular goiters with radioiodine

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Initially non-diagnostic ultrasound-guided fine needle aspiration cytology of thyroid nodules: value and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

How to manage thyroid nodules with two consecutive non-diagnostic results on ultrasonography-guided fine-needle aspiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

One month is sufficient for urinary iodine to return to its baseline value after the use of water-soluble iodinated contrast agents in post-thyroidectomy patients requiring radioiodine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Postoperative complications of thyroidectomy for differentiated thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

BRAF: a tool in the decision to perform elective neck dissection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Small differentiated thyroid cancer: time to reconsider clinical management and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Management of patients with low-risk papillary thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Preparation with recombinant human thyroid-stimulating hormone for thyroid remnant ablation with 131I is associated with lowered radiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Salivary and lacrimal gland dysfunction after remnant ablation with radioactive iodine in patients with differentiated thyroid carcinoma prepared with recombinant human thyrotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Second primary malignancies in thyroid cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Strategies of radioiodine ablation in patients with low-risk thyroid cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Recombinant human thyroid stimulating hormone-assisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Recombinant human thyrotropin in thyroid remnant ablation with 131-iodine in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Area under the curve of TSH after levothyroxine withdrawal versus administration of recombinant human TSH (rhTSH): possible implications for tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide plus lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Dietary iodine restriction in preparation for radioactive iodine treatment or scanning in well-differentiated thyroid cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Preablation stimulated thyroglobulin is a good predictor of successful ablation in patients with differentiated thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Associations of serum thyrotropin concentrations with recurrence and death in differentiated thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Development of a sensitive and specific quantitative reverse transcription-polymerase chain reaction assay for blood thyroglobulin messenger ribonucleic acid in the follow-up of patients with differentiated thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Value of diagnostic radioiodine whole-body scanning after initial therapy in patients with differentiated thyroid cancer at intermediate and high risk for recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Does undetectable basal Tg measured with a highly sensitive assay in the absence of antibodies and combined with normal ultrasonography ensure the absence of disease in patients treated for thyroid carcinoma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Empiric high-dose 131-iodine therapy lacks efficacy for treated papillary thyroid cancer patients with detectable serum thyroglobulin, but negative cervical sonography and 18F-fluorodeoxyglucose positron emission tomography scan

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Spontaneous remission in thyroid cancer patients after biochemical incomplete response to initial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Thyroglobulin measurements in washout of fine needle aspirates in cervical lymph nodes for detection of papillary thyroid cancer metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Cytotoxic chemotherapy for differentiated thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Targeted therapy in thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Inhibition of the Ras/Raf/MEK/ERK and RET kinase pathways with the combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Modified radical neck dissection for differentiated thyroid cancer: operative technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Prognostic indicators of outcomes in patients with distant metastases from differentiated thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Retinoic acid in patients with radioiodine non-responsive thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Outcome of palliative embolization of bone metastases in differentiated thyroid carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Pamidronate improves the quality of life and induces clinical remission of bone metastases in patients with thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Management of brain metastases from thyroid carcinoma: a study of 16 pathologically confirmed cases over 25 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Brain metastasis from follicular thyroid carcinoma: treatment with sorafenib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Five-year survival is similar in thyroid cancer patients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-27302013000400002

10.1590/S0004-27302013000400002

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23828432%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference